Article Per Year (5 Year)
p-Index From 2019 - 2024
0.444
P-Index
This Author published in this journals
All Journal Ophthalmologica Indonesiana Ophthalmologica Indonesiana
Gatot Suhartono
Unknown Affiliation
Health Professions Medicine & Pharmacology Physics Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Pemeriksaan SD-OCT Pada Bidang Neuro-oftalmologi Nurul Fitri; Gatot Suhartono
Majalah Oftalmologi Indonesia Vol 47 No 1 (2021): Ophthalmologica Indonesiana
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/journal.v47i1.100165

Abstract

Neuro-oftalmologi merupakan subdivisi luas yang befokus pada hubungan kelainan neurologis dengan kelainan mata. Modalitas diagnostik pada bidang ini mencakup anamnesa yang mendalam, pemeriksaan klinis, dan pemeriksaan penunjang yang lengkap. Optical coherence tomography (OCT) merupakan salah satu modalitas penunjang yang berkembang pesat dan banyak membantu diagnosis dan terapi dalam bidang oftalmologi. Teknologi terbaru dari OCT adalah Spectral Domain OCT (SD-OCT) yang mempunyai resolusi 2-3 kali lebih jelas dan kecepatan scanning 60-110 kali lebih cepat dibanding pendahulunya berupa Time Domain OCT (TD-OCT), menghadirkan scanning yang lebih menyeluruh dan menghasilkan gambaran 3 dimensi yang hampir mendekati gambaran histologis dari tiap lapisan. SD-OCT merupakan modalitas esensial untuk mengevaluasi keutuhan neuron, mengevaluasi progresifitas penyakit dan memprediksi perbaikan visus pasca operasi pada compressive optic neuropathy, menjadikan SD-OCT mempunyai potensi besar untuk membantu penegakan diagnosis dan terapi dari berbagai macam penyakit di bidang neuro-oftalmologi.
LONG-TERM FOLLOW-UP ON A RARE CASE OF PERIOPERATIVE POSTERIOR ISCHEMIC OPTIC NEUROPATHY: FINDING HOPE IN THE DARKNESS: Poster Presentation - Case Report - Resident Affannul Hakim; Lukisiari Agustini; Gatot Suhartono
Majalah Oftalmologi Indonesia Vol 49 No S2 (2023): Supplement Edition
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/5ghmr549

Abstract

Abstract Introduction : Perioperative posterior ischemic optic neuropathy (PION) following maxillectomy is a rare and devastating condition that leads to permanent vision loss in most reported cases. This case report offers a different perspective through long-term follow-up, providing valuable insights into the prognosis and potential treatments for PION. Case Illustration : Following a left maxillectomy for ameloblastoma, a 28-year-old female experienced sudden vision loss in her left eye. The visual acuity was 5/60, and an altitudinal inferior visual field defect with a superior extension was present. Ishihara's color vision examination revealed 15/38. The patient was diagnosed with perioperative PION and treated with neurotropic and folic acid. After 16 months, optic atrophy was observed. However, there are complete recovery in visual acuity to 5/5 and Ishihara score to 38/38, along with a significant improvement in the visual field defect. Discussion : The current management of perioperative PION is focused on prevention, because once vision loss occurs, it is usually severe and irreversible. In our case, the patient exhibited a favorable outcome after a long follow-up period, suggesting that there is still potential for improvement in PION patients. The finding is consistent with previous study, which reported that a small percentage of patients may still experience improved vision during follow-up. The role of neurotropics in improving patient outcomes is further supported by in vitro studies that demonstrate early neurotropic treatment significantly prevents loss of retinal ganglion cells in PION. Conclusion : Visual improvement is still possible in perioperative PION and early neurotropic administration may be considered in therapy
Co-Authors Affannul Hakim Lukisiari Agustini Nurul Fitri